KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Aurinia Pharmaceuticals (AUPH) Shares Repurchased (2024 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Shares Repurchased for 2 consecutive years, with $8.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Repurchased changed N/A year-over-year to $8.7 million, compared with a TTM value of $98.2 million through Dec 2025, up 143.93%, and an annual FY2025 reading of $98.2 million, up 143.93% over the prior year.
  • Shares Repurchased was $8.7 million for Q3 2025 at Aurinia Pharmaceuticals, down from $42.6 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $46.9 million in Q1 2025 and bottomed at $6.1 million in Q2 2024.